Last: | $6.82 |
---|---|
Change Percent: | -1.05% |
Open: | $6.72 |
Close: | $6.82 |
High: | $6.84 |
Low: | $6.7 |
Volume: | 566,993 |
Last Trade Date Time: | 05/13/2025 03:41:55 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.82 | $6.72 | $6.82 | $6.84 | $6.7 | 566,993 | 05-13-2025 |
$6.65 | $6.69 | $6.65 | $6.7197 | $6.63 | 571,841 | 05-12-2025 |
$6.49 | $6.61 | $6.49 | $6.6193 | $6.48 | 306,515 | 05-09-2025 |
$6.59 | $6.51 | $6.59 | $6.6398 | $6.46 | 956,861 | 05-08-2025 |
$6.44 | $6.36 | $6.44 | $6.45 | $6.36 | 361,746 | 05-07-2025 |
$6.38 | $6.38 | $6.38 | $6.4 | $6.34 | 358,714 | 05-06-2025 |
$6.44 | $6.4 | $6.44 | $6.48 | $6.39 | 519,732 | 05-05-2025 |
$6.43 | $6.43 | $6.43 | $6.5 | $6.41 | 568,332 | 05-02-2025 |
$6.4 | $6.34 | $6.4 | $6.45 | $6.3 | 799,760 | 05-01-2025 |
$6.27 | $6.27 | $6.27 | $6.27 | $6.15 | 847,080 | 04-30-2025 |
$6.33 | $6.3 | $6.33 | $6.35 | $6.2737 | 429,544 | 04-29-2025 |
$6.28 | $6.35 | $6.28 | $6.36 | $6.2487 | 675,328 | 04-28-2025 |
$6.28 | $6.27 | $6.28 | $6.35 | $6.2 | 1,673,611 | 04-25-2025 |
$6.11 | $5.92 | $6.11 | $6.12 | $5.92 | 451,177 | 04-24-2025 |
$5.92 | $5.96 | $5.92 | $6.06 | $5.9 | 621,586 | 04-23-2025 |
$5.85 | $5.74 | $5.85 | $5.89 | $5.7353 | 297,782 | 04-22-2025 |
$5.67 | $5.73 | $5.67 | $5.77 | $5.6301 | 518,943 | 04-21-2025 |
$5.89 | $5.81 | $5.89 | $5.895 | $5.8 | 481,076 | 04-18-2025 |
$5.89 | $5.81 | $5.89 | $5.895 | $5.8 | 481,076 | 04-17-2025 |
$5.85 | $5.87 | $5.85 | $5.9699 | $5.77 | 592,881 | 04-16-2025 |
News, Short Squeeze, Breakout and More Instantly...
Brooklyn ImmunoTherapeutics Inc. Company Name:
BTX Stock Symbol:
NYSE Market:
-1.05% G/L:
$6.82 Last:
566,993 Volume:
$6.72 Open:
$6.82 Close:
Brooklyn ImmunoTherapeutics Inc. Website:
BlackRock Advisors, LLC announced today the results of the Special Shareholder Meeting of the BlackRock Technology and Private Equity Term Trust (NYSE: BTX) (the “Trust”). Shareholders have approved (i) an amendment to the Trust’s fundamental investment restriction with respe...
2025-04-07 05:00:31 ET I often talk about high-yielding closed-end funds (CEFs) that are great buys because, well, there are plenty of CEFs that are. Yes, even in unprecedented times like these! That’s because the best CEFs offer three things we love: Big dividends, wit...
2025-03-13 05:00:19 ET There are two things I need to bring to your attention right now, especially if you’re an income investor. One is my outlook for the market, as volatility really hits home. The other is a 15.6%-yielding(!) fund that just changed its name and ticker ...